Pelvic lymph node metastases visualized on PSMA PET/CT prior to prostate cancer surgery independently predicts an increased risk for biochemical disease progression, a study found.
Study findings suggest that PSMA PET results may alter treatment decisions in high-risk prostate cancer.
But difference in positive margin rates between usual planning and 3D virtual reality model planning groups not statistically significant
A novel scoring system could identify men at increased risk of death after prostatectomy who would benefit from adjuvant radiation therapy.
A recent study is the first to examine the association between pelvic inflammation and prostate cancer biology and outcomes.
Persistent vs undetectable PSA after salvage radical prostatectomy is significantly associated with an increased risk for biochemical recurrence, metastasis, and death, investigators reported.
Intraoperative pathologic assessment of tissue adjacent to the neurovascular bundles after removal of the prostate increases the likelihood of nerve-sparing surgery.
Patients with perineural invasion had a 4-fold higher risk of biochemical recurrence.
The likelihood of conversion from HoLEP to an open procedure to treat benign prostatic hyperplasia increases along with prostate size.
In patients with high-risk prostate cancer, negative PSMA PET/CT does not permit PLND avoidance, investigators cautioned.
